Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF--a new player in hematological neoplasms.

Blood cells, molecules & diseases - 1 Jan 2000

Machnicki Marcin M, Stoklosa Tomasz

Abstract excerpt

BRAF oncogenic kinase has become a target for specific therapy in oncology. Genetic characterization of a predominant V600E mutation in melanoma, thyroid cancer, and other tumors became a focus for developing specific inhibitors, such as vemurafenib or dabrafenib. Our knowledge regarding the role of mutated BRAF in hematological malignancies has grown quickly as a result of new genetic techniques such as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRAF gene
Share to Hematologic Neoplasms
Share to Molecular Targeted Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Source

Identifiers

PMID: 24495477
DOI: 10.1016/j.bcmd.2014.01.001

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF--a new player in hematological neoplasms.PMID 24495477Read ↗

The BRAF-V600E mutation in hematological malignancies: a new player in hairy cell leukemia and Langerhans cell histiocytosis.Semantic proximity Read ↗

BRAF mutation in hairy cell leukemiaSemantic proximity Read ↗

[Molecular and therapeutic advances in Hairy cell leukemia].Semantic proximity Read ↗

MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age.Semantic proximity Read ↗

BRAF mutation in myeloid neoplasm: incidences and clinical outcomes.Semantic proximity Read ↗

BRAF Mutations: Oncogenic Drivers in Solid TumorsSemantic proximity Read ↗

Mutations in the Serine/Threonine Kinase BRAF: Oncogenic Drivers in Solid TumorsSemantic proximity Read ↗

BRAFmutation testing in clinical practiceSemantic proximity Read ↗

BRAF V600E mutation in hairy cell leukemia: from bench to bedsideSemantic proximity Read ↗

Targeting Oncogenic BRAF: Past, Present, and FutureSemantic proximity Read ↗

BRAF mutations: signaling, epidemiology, and clinical experience in multiple malignancies.Semantic proximity Read ↗

BRAF: A Two-Faced Janus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.